Breznianske Centrum Gastroenterologie s.r.o.
- Address
- Banisko 1, 977 01 Brezno, Slovakia
Breznianske Centrum Gastroenterologie s.r.o.
Breznianske Centrum Gastroenterologie s.r.o. is a specialized gastroenterology research center dedicated to advancing the understanding and treatment of inflammatory bowel diseases. The center participates in multinational phase III clinical trials evaluating novel therapeutic approaches for patients with gastrointestinal disorders.
- Ulcerative colitis treatment and remission induction therapies
- Oral mesalazine formulations and comparative effectiveness studies
- Endoscopic assessment and clinical remission monitoring in inflammatory bowel disease
The center's research focuses on evaluating oral mesalazine formulations for patients with active mild to moderate ulcerative colitis, utilizing comprehensive assessment tools including clinical remission scoring, endoscopic evaluation, and patient-reported outcomes. Their expertise extends to non-inferiority trial designs that compare emerging treatment options with established therapies, contributing valuable data to optimize therapeutic strategies for achieving both symptomatic and endoscopic remission in inflammatory bowel disease patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Breznianske Centrum Gastroenterologie s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Aug 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tulisokibart | 1 | Unknown | 2024-08-20 | 2024-08-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.